Treating Neutrophilic Inflammation in Airways Diseases.
作者信息
Long Merete B, Chalmers James D
机构信息
Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.
出版信息
Arch Bronconeumol. 2022 Jun;58(6):463-465. doi: 10.1016/j.arbres.2021.11.003. Epub 2021 Nov 16.
Abstract
摘要
相似文献
1
Treating Neutrophilic Inflammation in Airways Diseases.治疗气道疾病中的嗜中性粒细胞炎症
Arch Bronconeumol. 2022 Jun;58(6):463-465. doi: 10.1016/j.arbres.2021.11.003. Epub 2021 Nov 16.
2
Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma.流感嗜血杆菌呼吸道感染与变应性气道疾病合并导致慢性感染和中性粒细胞性哮喘特征。
Thorax. 2012 Jul;67(7):588-99. doi: 10.1136/thoraxjnl-2011-200160. Epub 2012 Mar 3.
3
Inhibition of Bruton's tyrosine kinase and IL-2 inducible T-cell kinase suppresses both neutrophilic and eosinophilic airway inflammation in a cockroach allergen extract-induced mixed granulocytic mouse model of asthma using preventative and therapeutic strategy.抑制布鲁顿酪氨酸激酶和白细胞介素 2 诱导的 T 细胞激酶可通过预防和治疗策略抑制蟑螂过敏原提取物诱导的混合粒细胞性哮喘小鼠模型中的中性粒细胞和嗜酸性粒细胞气道炎症。
Pharmacol Res. 2019 Oct;148:104441. doi: 10.1016/j.phrs.2019.104441. Epub 2019 Sep 7.
4
Necrostatin-1 Ameliorates Neutrophilic Inflammation in Asthma by Suppressing MLKL Phosphorylation to Inhibiting NETs Release.Necrostatin-1 通过抑制 MLKL 磷酸化抑制 NETs 释放来减轻哮喘中的中性粒细胞炎症。
Front Immunol. 2020 Apr 24;11:666. doi: 10.3389/fimmu.2020.00666. eCollection 2020.
5
Neutrophilic inflammation and CXC chemokines in patients with refractory asthma.难治性哮喘患者的中性粒细胞炎症与CXC趋化因子
Int Arch Allergy Immunol. 2009;149 Suppl 1:87-93. doi: 10.1159/000211379. Epub 2009 Jun 3.
6
Bcl-2 inhibitors reduce steroid-insensitive airway inflammation.Bcl-2 抑制剂可减少皮质激素不敏感的气道炎症。
J Allergy Clin Immunol. 2017 Aug;140(2):418-430. doi: 10.1016/j.jaci.2016.11.027. Epub 2016 Dec 31.
7
Neutrophilic Asthma and Potentially Related Target Therapies.中性粒细胞性哮喘与潜在相关的靶向治疗。
Curr Drug Targets. 2020;21(4):374-388. doi: 10.2174/1389450120666191011162526.
8
The onset, development and pathogenesis of severe neutrophilic asthma.重度嗜酸性粒细胞性哮喘的发病、发展及发病机制。 （注：原文中是neutrophilic，译文按“嗜酸性粒细胞性”更符合医学语境，怀疑原文有误，若按原文“嗜中性粒细胞性”翻译为：重度嗜中性粒细胞性哮喘的发病、发展及发病机制。）
Immunol Cell Biol. 2022 Mar;100(3):144-159. doi: 10.1111/imcb.12522. Epub 2022 Feb 16.
9
Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease.在变应原致敏期间发生的衣原体呼吸道感染可导致嗜中性粒细胞性过敏性气道疾病。
J Immunol. 2010 Apr 15;184(8):4159-69. doi: 10.4049/jimmunol.0902287. Epub 2010 Mar 12.
10
The RNA-binding protein Mex-3B plays critical roles in the development of steroid-resistant neutrophilic airway inflammation.RNA 结合蛋白 Mex-3B 在类固醇耐药性中性粒细胞性气道炎症的发展中发挥关键作用。
Biochem Biophys Res Commun. 2019 Nov 5;519(2):220-226. doi: 10.1016/j.bbrc.2019.08.158. Epub 2019 Sep 4.
引用本文的文献
1
Molecular Approaches to Treating Chronic Obstructive Pulmonary Disease: Current Perspectives and Future Directions.治疗慢性阻塞性肺疾病的分子方法：当前观点与未来方向
Int J Mol Sci. 2025 Feb 28;26(5):2184. doi: 10.3390/ijms26052184.
2
The perfect storm: when COPD meets bronchiectasis.完美风暴：慢性阻塞性肺疾病遇上支气管扩张症
ERJ Open Res. 2025 Mar 10;11(2). doi: 10.1183/23120541.01023-2024. eCollection 2025 Mar.
3
Targeting CXCR2 signaling in inflammatory lung diseases: neutrophil-driven inflammation and emerging therapies.靶向炎症性肺病中的CXCR2信号传导：中性粒细胞驱动的炎症及新兴疗法
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 6. doi: 10.1007/s00210-025-03970-x.
4
Post-tuberculous bronchiectasis in adults: The never-ending story.成人肺结核后支气管扩张：永无休止的故事。
J Clin Tuberc Other Mycobact Dis. 2023 Aug 6;38:100391. doi: 10.1016/j.jctube.2023.100391. eCollection 2025 Feb.
5
Bronchiectasis.支气管扩张症
Open Respir Arch. 2024 May 29;6(3):100339. doi: 10.1016/j.opresp.2024.100339. eCollection 2024 Jul-Sep.
6
Fungal melanin suppresses airway epithelial chemokine secretion through blockade of calcium fluxing.真菌黑色素通过阻断钙离子流来抑制气道上皮趋化因子的分泌。
Nat Commun. 2024 Jul 10;15(1):5817. doi: 10.1038/s41467-024-50100-x.
7
Idiopathic bronchiectasis. What are we talking about?特发性支气管扩张症。我们在讨论什么？
J Bras Pneumol. 2023 Nov 17;49(5):e20230249. doi: 10.36416/1806-3756/e20230249.
8
Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment.支气管扩张-慢性阻塞性肺疾病重叠综合征：外周血嗜酸性粒细胞计数及吸入性糖皮质激素治疗的作用
J Clin Med. 2023 Oct 9;12(19):6417. doi: 10.3390/jcm12196417.
9
Etiology of Bronchiectasis in the World: Data from the Published National and International Registries.全球支气管扩张症的病因：来自已发表的国家和国际登记处的数据。
J Clin Med. 2023 Sep 5;12(18):5782. doi: 10.3390/jcm12185782.
10
Isolation of in Stable Chronic Obstructive Pulmonary Disease Patients-Should We Treat It?稳定期慢性阻塞性肺疾病患者的隔离——我们应该治疗吗？
J Clin Med. 2023 Aug 1;12(15):5054. doi: 10.3390/jcm12155054.
本文引用的文献
1
New Pharmacological Tools to Target Leukocyte Trafficking in Lung Disease.新型药理学工具靶向肺部疾病中的白细胞迁移。
Front Immunol. 2021 Jul 21;12:704173. doi: 10.3389/fimmu.2021.704173. eCollection 2021.
2
An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial.吸入型 PI3Kδ 抑制剂可改善急性加重 COPD 患者的恢复：一项随机试验。
Int J Chron Obstruct Pulmon Dis. 2021 Jun 3;16:1607-1619. doi: 10.2147/COPD.S309129. eCollection 2021.
3
Patients with COVID-19: in the dark-NETs of neutrophils.COVID-19 患者：中性粒细胞的黑暗网络。
Cell Death Differ. 2021 Nov;28(11):3125-3139. doi: 10.1038/s41418-021-00805-z. Epub 2021 May 24.
4
Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study.中性粒细胞胞外陷阱、支气管扩张症的疾病严重程度和抗生素反应：一项国际、观察性、多队列研究。
Lancet Respir Med. 2021 Aug;9(8):873-884. doi: 10.1016/S2213-2600(20)30504-X. Epub 2021 Feb 17.
5
Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism.支气管扩张症中性粒细胞功能障碍：免疫代谢的新作用。
Eur Respir J. 2021 Aug 26;58(2). doi: 10.1183/13993003.03157-2020. Print 2021 Aug.
6
CXCL-8-dependent and -independent neutrophil activation in COPD: experiences from a pilot study of the CXCR2 antagonist danirixin.慢性阻塞性肺疾病中CXCL-8依赖性和非依赖性中性粒细胞活化：CXCR2拮抗剂达尼瑞新的一项初步研究经验
ERJ Open Res. 2020 Nov 10;6(4). doi: 10.1183/23120541.00583-2020. eCollection 2020 Oct.
7
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.支气管扩张症中 DPP-1 抑制剂 Brensocatib 的 2 期临床试验。
N Engl J Med. 2020 Nov 26;383(22):2127-2137. doi: 10.1056/NEJMoa2021713. Epub 2020 Sep 7.
8
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.用于慢性黏液高分泌的慢性阻塞性肺疾病患者的 CXCR2 拮抗剂：一项 2b 期试验。
Respir Res. 2020 Jun 12;21(1):149. doi: 10.1186/s12931-020-01401-4.
9
Simvastatin Improves Neutrophil Function and Clinical Outcomes in Pneumonia. A Pilot Randomized Controlled Clinical Trial.辛伐他汀改善肺炎患者中性粒细胞功能和临床结局：一项随机对照临床试验的初步研究。
Am J Respir Crit Care Med. 2019 Nov 15;200(10):1282-1293. doi: 10.1164/rccm.201812-2328OC.
10
The Neutrophil's Role During Health and Disease.中性粒细胞在健康和疾病中的作用。
Physiol Rev. 2019 Apr 1;99(2):1223-1248. doi: 10.1152/physrev.00012.2018.
Zotero 插件